Times of India
AsiaPac · 3 hrs ago
Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive
US President Donald Trump on Tuesday announced the final stage of his pharmaceutical tariff plan, under which imported generic medicines will continue to enter the US without duties until August 1, 2028.
Do you trust Times of India?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!